Cipla signs licensing deal with Lilly to manufacture and commercialise baricitinib in India
Baricitinib was issued a restricted emergency use approval by CDSCO to treat COVID-19
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
baricitinib
Eli Lilly accelerates baricitinib’s availability in India
Lilly is working with the Indian government to provide baricitinib donations in conjunction with the permission
Olumniant (barcitinab) from Eli Lilly gets EUA from US FDA for COVID-19 treatment
Baricitinib is an FDA-approved drug to treat rheumatoid arthritis
Baricitinib in combination with remdesivir reduces recovery time in hospitalised COVID-19 patients:…
Data from the Adaptive COVID-19 Treatment Trial (ACTT-2) revealed an approximately one-day reduction in median recovery time for…
Gilead, AstraZeneca and Pfizer may be winners in race for COVID-19 therapeutics and vaccines:…
There is no shortage of candidates to help with COVID-19, but what is lacking right now is data on their efficacy